T cell-mediated immune response to respiratory coronaviruses.
about
The host immune response in respiratory virus infection: balancing virus clearance and immunopathology.Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection.Severe acute respiratory syndrome coronaviruses with mutations in the E protein are attenuated and promising vaccine candidates.SARS-CoV virus-host interactions and comparative etiologies of acute respiratory distress syndrome as determined by transcriptional and cytokine profiling of formalin-fixed paraffin-embedded tissues.Critical role of phospholipase A2 group IID in age-related susceptibility to severe acute respiratory syndrome-CoV infection.Identification of the Mechanisms Causing Reversion to Virulence in an Attenuated SARS-CoV for the Design of a Genetically Stable Vaccine.Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice.3B11-N, a monoclonal antibody against MERS-CoV, reduces lung pathology in rhesus monkeys following intratracheal inoculation of MERS-CoV Jordan-n3/2012Intratracheal exposure of common marmosets to MERS-CoV Jordan-n3/2012 or MERS-CoV EMC/2012 isolates does not result in lethal diseaseEfficient Reverse Genetic Systems for Rapid Genetic Manipulation of Emergent and Preemergent Infectious Coronaviruses.Airway Memory CD4(+) T Cells Mediate Protective Immunity against Emerging Respiratory Coronaviruses.Systemic and mucosal immunity in mice elicited by a single immunization with human adenovirus type 5 or 41 vector-based vaccines carrying the spike protein of Middle East respiratory syndrome coronavirus.Characteristics of Traveler with Middle East Respiratory Syndrome, China, 2015.Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome: Current Therapeutic Options and Potential Targets for Novel Therapies.Middle East respiratory syndrome.Current understanding of middle east respiratory syndrome coronavirus infection in human and animal models
P2860
Q26766467-2ABA0391-C6BD-43C0-A5A1-B76B5E993A5EQ34261999-AFE0EAC9-1023-4538-9881-F71ED9B1DF93Q35487951-499CCD02-FC66-4660-B89D-FCBF992D88D3Q35834692-F9CEBB18-4B37-4894-9C22-473E1CC739FFQ36180681-3288EC11-8666-4677-AC3B-C5960F2A89B3Q36224671-9BFA8169-92C3-4E35-85A7-DC98ECF71ACEQ36577616-D2C322E3-65AC-48BB-9887-7F0EB226245AQ36626864-C565197A-9450-44D9-9E1A-D440849F3740Q37211511-101A9ABF-A2B2-4930-B9EA-1CD10D3E5AEDQ40200075-18F2D307-464A-44C8-8DA3-7D44240B40D0Q40707492-305DD8FF-D1A6-4F76-92F5-F269AB0C28A1Q41242033-80AA126C-E92A-426F-B32A-2E84870A2147Q43140339-33427686-6840-417A-BA78-42BA992B0ED0Q43280688-38FCA723-B8AF-46F4-A994-92E78D81E4C6Q51011540-78EE289E-5155-41D0-97B3-8D1AC08830C2Q56971688-7D79AEE7-055C-404D-8B29-CF8F8FC17E03
P2860
T cell-mediated immune response to respiratory coronaviruses.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
T cell-mediated immune response to respiratory coronaviruses.
@en
type
label
T cell-mediated immune response to respiratory coronaviruses.
@en
prefLabel
T cell-mediated immune response to respiratory coronaviruses.
@en
P2860
P1433
P1476
T cell-mediated immune response to respiratory coronaviruses.
@en
P2093
Jincun Zhao
Rudragouda Channappanavar
P2860
P2888
P304
P356
10.1007/S12026-014-8534-Z
P577
2014-08-01T00:00:00Z
P6179
1024254679